Primary central nervous system lymphoma in a patient with multiple sclerosis using fingolimod

被引:3
作者
Morillos, Matheus Bernardon [1 ]
Pires de Aguiar, Paulo Henrique [2 ]
Franceschini, Paulo Roberto [3 ]
Duarte, Juliana Avila [4 ]
Piccini, Cristian Daniel [5 ]
Finkelsztejn, Alessandro [1 ]
机构
[1] Hosp Clin Porto Alegre, Dept Neurol, Porto Alegre, RS, Brazil
[2] Pontificia Univ Catolica Sao Paulo, Dept Neurol, Sao Paulo, Brazil
[3] Hosp Saude, Dept Neurosurg, Caxias Do Sul, RS, Brazil
[4] Hosp Clin Porto Alegre, Dept Internal Med, Porto Alegre, RS, Brazil
[5] Univ Fed Rio Grande do Sul, Fac Med, Rua Ramiro Barcelos 2400, BR-90035002 Porto Alegre, RS, Brazil
关键词
Lymphoma; Fingolimod; Multiple sclerosis; CNS; Primary; Brain; CELL LYMPHOMA;
D O I
10.1007/s10072-022-06367-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Primary central nervous system lymphoma (PCNSL) is an uncommon lymphoproliferative disease associated with immunosuppression. Here, we report the case of a patient with multiple sclerosis, under treatment with fingolimod (FTY720, Gilenya) for 4 years, who developed this condition. Although the causal relationship cannot be established, there are cases in the literature that describe the appearance of lymphoma after the use of this medication. Considering the high mortality of PCNSL, epidemiological studies are necessary to establish a relationship between its arising and the use of immunosuppressants.
引用
收藏
页码:361 / 363
页数:3
相关论文
共 13 条
[1]   Primary mediastinal large B-cell lymphoma in a patient on Fingolimod for relapsing-remitting multiple sclerosis [J].
Chacko, Joseph A. ;
Strati, Paolo ;
Stout, Paul W. ;
Archer, Robert L. ;
Baltz, Brad P. ;
Chacko, Joseph G. .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 49
[2]   Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis [J].
Christopher, Karen L. ;
Elner, Victor M. ;
Demirci, Hakan .
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2017, 33 (03) :E73-E75
[3]   Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders [J].
Chun, Jerold ;
Kihara, Yasuyuki ;
Jonnalagadda, Deepa ;
Blaho, Victoria A. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59, 2019, 59 :149-170
[4]   Primary central nervous system lymphoma [J].
Citterio, Giovanni ;
Reni, Michele ;
Gatta, Gemma ;
Ferreri, Andres Jose Maria .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 113 :97-110
[5]   Spontaneous regression of tumor-stage cutaneous T-cell lymphoma in a multiple sclerosis patient after discontinuing fingolimod [J].
Froehlich, Anne ;
Schmidt, Stephan ;
Landsberg, Jenny ;
Bieber, Thomas ;
Wenzel, Joerg .
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (13) :1785-1786
[6]   An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis [J].
Garg, Neeta ;
Smith, Thomas W. .
BRAIN AND BEHAVIOR, 2015, 5 (09)
[7]   Peripheral T-cell lymphomas as fingolimod-associated lymphoproliferative disorder for patients with multiple sclerosis-case report with literature review [J].
Kawai, Hidetsugu ;
Matsushita, Hiromichi ;
Akashi, Hibiki ;
Furuya, Daisuke ;
Kawakami, Shohei ;
Suzuki, Rikio ;
Moriuchi, Makiko ;
Ogawa, Yoshiaki ;
Kawada, Hiroshi ;
Nakamura, Naoya ;
Ando, Kiyoshi .
LEUKEMIA & LYMPHOMA, 2020, 61 (04) :959-962
[8]   Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension [J].
Kira, Jun-ichi ;
Itoyama, Yasuto ;
Kikuchi, Seiji ;
Hao, Qi ;
Kurosawa, Takayoshi ;
Nagato, Kazuo ;
Tsumiyama, Isao ;
von Rosenstiel, Philipp ;
Zhang-Auberson, Lixin ;
Saida, Takahiko .
BMC NEUROLOGY, 2014, 14
[9]   Autoimmune conditions and primary central nervous system lymphoma risk among older adults [J].
Mahale, Parag ;
Herr, Megan M. ;
Engels, Eric A. ;
Pfeiffer, Ruth M. ;
Shiels, Meredith S. .
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (04) :516-521
[10]   Cutaneous anaplastic large cell lymphoma in a multiple sclerosis patient receiving Fingolimod [J].
Manouchehri, Navid ;
Mirmosayyeb, Omid ;
Badihian, Shervin ;
Shaygannejad, Vahid .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 19 :121-123